HZNP
Alyeska Investment Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,113
| Closed | -$354K | – | 561 |
|
|
2022
Q4 | $354K | Buy |
+3,113
| New | +$354K | ﹤0.01% | 382 |
|
|
2022
Q3 | – | Sell |
-572,136
| Closed | -$45.6M | – | 689 |
|
|
2022
Q2 | $45.6M | Buy |
572,136
+75,833
| +15% | +$6.05M | 0.52% | 50 |
|
|
2022
Q1 | $52.2M | Sell |
496,303
-44,122
| -8% | -$4.64M | 0.58% | 48 |
|
|
2021
Q4 | $58.2M | Buy |
540,425
+65,368
| +14% | +$7.04M | 0.67% | 40 |
|
|
2021
Q3 | $52M | Buy |
+475,057
| New | +$52M | 0.64% | 29 |
|
|
2020
Q4 | – | Sell |
-100,000
| Closed | -$7.77M | – | 687 |
|
|
2020
Q3 | $7.77M | Buy |
+100,000
| New | +$7.77M | 0.12% | 211 |
|
|
2020
Q2 | – | Sell |
-1,175,353
| Closed | -$34.8M | – | 587 |
|
|
2020
Q1 | $34.8M | Buy |
1,175,353
+275,468
| +31% | +$8.16M | 0.69% | 49 |
|
|
2019
Q4 | $32.6M | Sell |
899,885
-265,604
| -23% | -$9.61M | 0.43% | 87 |
|
|
2019
Q3 | $31.7M | Sell |
1,165,489
-10,689
| -0.9% | -$291K | 0.46% | 79 |
|
|
2019
Q2 | $28.3M | Buy |
1,176,178
+447,999
| +62% | +$10.8M | 0.37% | 93 |
|
|
2019
Q1 | $19.2M | Buy |
728,179
+698,460
| +2,350% | +$18.5M | 0.25% | 120 |
|
|
2018
Q4 | $581K | Buy |
+29,719
| New | +$581K | 0.01% | 294 |
|
|
2018
Q2 | – | Sell |
-445,452
| Closed | -$6.33M | – | 548 |
|
|
2018
Q1 | $6.33M | Buy |
+445,452
| New | +$6.33M | 0.05% | 247 |
|
|
2014
Q3 | – | Sell |
-200,000
| Closed | -$3.16M | – | 467 |
|
|
2014
Q2 | $3.16M | Sell |
200,000
-257,760
| -56% | -$4.08M | 0.07% | 251 |
|
|
2014
Q1 | $6.92M | Buy |
+457,760
| New | +$6.92M | 0.19% | 138 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 358 |
|
|
2013
Q3 | – | Sell |
-384,693
| Closed | -$946K | – | 320 |
|
|
2013
Q2 | $946K | Buy |
+384,693
| New | +$946K | 0.05% | 208 |
|